Drugs: immunologic

Open Access
Five things to know about …: NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection
Sabina Vohra-Miller and Ilan S. Schwartz

CMAJ September 12, 2022 194 (35) E1214; DOI: https://doi.org/10.1503/cmaj.220688
Open Access
Pre-exposure prophylaxis for HIV: effective and underused
Amanda Hempel, Mia J. Biondi, Jean-Guy Baril and Darrell H.S. Tan

CMAJ September 06, 2022 194 (34) E1164-E1170; DOI: https://doi.org/10.1503/cmaj.220645
Open Access
Severity of COVID-19 among solid organ transplant recipients in Canada, 2020–2021: a prospective, multicentre cohort study
Victoria G. Hall, Javier T. Solera, Ghadeer Al-Alahmadi, Tina Marinelli, Heloise Cardinal, Charles Poirier, Geneviève Huard, G.V. Ramesh Prasad, Sacha A. De Serres, Debra Isaac, Rahul Mainra, Caroline Lamarche, Ruth Sapir-Pichhadze, Susan Gilmour, Atul Humar and Deepali Kumar

CMAJ August 29, 2022 194 (33) E1155-E1163; DOI: https://doi.org/10.1503/cmaj.220620
Open Access
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis
Kevin Yau, Christopher T. Chan, Kento T. Abe, Yidi Jiang, Mohammad Atiquzzaman, Sarah I. Mullin, Ellen Shadowitz, Lisa Liu, Ema Kostadinovic, Tatjana Sukovic, Anny Gonzalez, Margaret E. McGrath-Chong, Matthew J. Oliver, Jeffrey Perl, Jerome A. Leis, Shelly Bolotin, Vanessa Tran, Adeera Levin, Peter G. Blake, Karen Colwill, Anne-Claude Gingras and Michelle A. Hladunewich

CMAJ February 28, 2022 194 (8) E297-E305; DOI: https://doi.org/10.1503/cmaj.211881
Open Access
Should Canadian patients look forward to aducanumab for Alzheimer disease?
Jennifer A. Watt, Roger Marple, Brenda Hemmelgarn and Sharon E. Straus

CMAJ September 13, 2021 193 (36) E1430-E1431; DOI: https://doi.org/10.1503/cmaj.211134
Open Access
Cases: Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination
Julie Robichaud, Catherine Côté and Fanny Côté

CMAJ August 30, 2021 193 (34) E1341-E1344; DOI: https://doi.org/10.1503/cmaj.211212
Open Access
Five Things to Know About ...: Heparin-induced thrombocytopenia
Stefan D. Jevtic, Andrew M. Morris, Theodore E. Warkentin and Menaka Pai

CMAJ May 17, 2021 193 (20) E736; DOI: https://doi.org/10.1503/cmaj.210637
Open Access
Cases: Disseminated cryptococcal infection in a patient with a remote renal transplant
Kelli Li, Abid Khan, Sharmistha Mishra and Alice Zhabokritsky

CMAJ February 08, 2021 193 (6) E211-E214; DOI: https://doi.org/10.1503/cmaj.200825
Open Access
Five things to know about …: Using intranasal corticosteroids
James Fowler and Leigh J Sowerby

CMAJ January 11, 2021 193 (2) E47; DOI: https://doi.org/10.1503/cmaj.201266
You have access
Five things to know about …: Immune checkpoint inhibitors in cancer immunotherapy
Megan E. Himmel, Samuel D. Saibil and Alexandra P. Saltman

CMAJ June 15, 2020 192 (24) E651; DOI: https://doi.org/10.1503/cmaj.191231

Main menu

User menu

Search

Drugs: immunologic

Pages

Content

Information for

About